This Axolotl Biologix compendium presents research and clinical evidence for its dehydrated human amnion allografts (Axolotl Graft™ and DualGraft™), used as protective barriers for acute and chronic wounds. It compiles four reviews, three case studies, a case series, poster presentations, and an ongoing diabetic foot ulcer RCT (NCT06550596), documenting the membrane’s ECM composition, biocompatibility, low immunogenicity, and wound-closure outcomes across diverse clinical applications.